Clozapine, negative symptoms, and extrapyramidal side effects. 1994

J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
Hillside Hospital, Division of Long Island Jewish Medical Center, Glen Oaks, N.Y. 11004.

The importance of persistent negative symptoms in schizophrenia as a limiting factor in psychosocial and vocational rehabilitation has been increasingly emphasized. As a result, treatment trials and new drug development programs are focusing more attention on negative symptoms. Unfortunately, there is enormous phenomenological overlap between negative symptoms and neuroleptic-induced parkinsonism. We report data from a cohort of 56 clozapine-treated patients demonstrating significant correlations between measures of akinesia and anergia. Despite an average drug washout of over 2 weeks, the persistence of drug-induced parkinsonism can confound the assessment of therapeutic drug effects on negative symptoms.

UI MeSH Term Description Entries
D008297 Male Males
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001480 Basal Ganglia Diseases Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. Extrapyramidal Disorders,Basal Ganglia Disorders,Lenticulostriate Disorders,Basal Ganglia Disease,Basal Ganglia Disorder,Extrapyramidal Disorder,Lenticulostriate Disorder

Related Publications

J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
March 1995, Psychopharmacology,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
January 2017, Rivista di psichiatria,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
June 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
January 2000, Psychopathology,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
January 1998, Psychopharmacology bulletin,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
October 1993, Archives of general psychiatry,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
January 1993, Psychopharmacology bulletin,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
March 1996, Psychopharmacology,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
October 1975, Der Nervenarzt,
J M Kane, and A Z Safferman, and S Pollack, and C Johns, and S Szymanski, and M Kronig, and J A Lieberman
January 2004, Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Copied contents to your clipboard!